Halozyme Therapeutics Inc (NAS:HALO)
$ 38.11 -0.67 (-1.73%) Market Cap: 4.84 Bil Enterprise Value: 6.09 Bil PE Ratio: 18.06 PB Ratio: 57.73 GF Score: 83/100

Halozyme Therapeutics Inc (HALO) Transcripts

  • 1